Skip to main content
. 2021 Oct 13;10(2):1691–1708. doi: 10.1007/s40122-021-00331-3

Table 1.

Characteristics of the BECOME study population

Part 1 (N = 20,837)
Characteristics
 No PPTF 7880 (37.8)
 ≥ 1 PPTF 12,957 (62.2)
 < 4 MMD 5358 (25.7)
 ≥ 4 MMD 15,479 (74.3)
 Medication overuse 3706 (17.8)
 Medication overuse headache 2464 (11.8)
 New patient to the center 5621 (27.0)
 Follow-up patient to the center 15,216 (73.0)
 Outpatient visits 19,700 (94.5)
 Inpatient visits 650 (3.1)
 Unclassified visits 487 (2.3)
Part 2 (N = 2419)
Demographics
 Age, mean (SD), years 43.0 (11.6)
 Women 2103 (86.9)
 Married 1276 (52.7)
 Employed (full time or part time) 1480 (61.2)
 Living independently (alone/with spouse/others) 1991 (82.3)
 University education 949 (39.2)
Clinical characteristics
 Migraine duration
  < 5 years 213 (8.8)
  6 to 10 years 287 (11.9)
  11 to 15 years 274 (11.3)
   > 15 years 1641 (67.8)
Time since experiencing the first migraine headache, mean (SD), years 23.5 (13.2)
Time since diagnosis of migraine, mean (SD), years 15.7 (11.9)
 Type of migrainea
  Migraine without aura 1291 (53.4)
  Migraine with aura 290 (12.0)
  Chronic migraine 731 (30.2)
  Complications of migraineb 9 (0.4)
  Probable migraine 2 (0.1)
  Episodic syndromes that may be associated with migraine 6 (0.2)
Medication overuse 627 (25.9)
Medication overuse headache 571 (23.6)
New patient to the center 555 (22.9)
Follow-up patient to the center 1863 (77.0)
Inpatient 103 (4.3)
Outpatient with ED visit 416 (17.2)
Outpatient without ED visit 1899 (78.5)
Patients with presence of comorbidities 1479 (61.1)
Number of co-morbidities per patient, mean (SD) 1.3 (1.6)
 Most common comorbidities (≥ 10%)
  Psychiatric disorders 532 (22.0)
  Musculoskeletal and connective tissue disorders 322 (13.3)
  Gastrointestinal disorders 250 (10.3)
  Vascular disorders 249 (10.3)
  Endocrine disorders 246 (10.2)

All values are n (%), unless indicated

ED emergency department, ICHD International Classification of Headache Disorders, MMD monthly migraine days, N total number of patients in part 1 or part 2, PPTF prior preventive treatment failure, SD standard deviation

aDiagnosis according to ICHD-3 code

bMigraine complications that were assessed were status migrainosus, persistent aura without infarction, migrainous infarction, and migraine aura-triggered seizure